MA27309A1 - ORODISPERSIBLE TABLETS AND PROCESSES FOR OBTAINING THEM - Google Patents
ORODISPERSIBLE TABLETS AND PROCESSES FOR OBTAINING THEMInfo
- Publication number
- MA27309A1 MA27309A1 MA27981A MA27981A MA27309A1 MA 27309 A1 MA27309 A1 MA 27309A1 MA 27981 A MA27981 A MA 27981A MA 27981 A MA27981 A MA 27981A MA 27309 A1 MA27309 A1 MA 27309A1
- Authority
- MA
- Morocco
- Prior art keywords
- weight
- particle size
- mixing
- active ingredient
- tablets
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000314 lubricant Substances 0.000 abstract 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 2
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 2
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 abstract 1
- 238000007907 direct compression Methods 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000008447 perception Effects 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Les comprimés comprennent: au moins 59,5% de mannitol séché par atomisation; l'ingrédient actif inférieur ou égal à 10%, oé au moins 90% en poids de l'ingrédient actif a une dimension particulaire de moins de 100 Ám; de la cellulose microcristalline 10-18%, ayant une dimension particulaire moyenne de 50 Ám et oé au moins 99% en poids de la cellulose microcristalline ont une dimension particulaire au-dessous de 250 Ám; de la croscarmellose de sodium 1-4%; et un agent lubrifiant 0,5-2%; oé, sauf indication contraire, les pourcentages sont exprimés en poids du poids total du comprimé. Et aussi un processus comprenant: le tamisage et le mélange des composants à l'exception de l'agent lubrifiant; le mélange de tous les composants; et la compression directe du mélange final. Les comprimés de l'invention diminuent les temps de désagrégation, donnent une bonne perception sur la langue après la désagrégation, et surmontent le problème de la résistance mécanique insuffisante pour les opérations d'emballage et de transport.The tablets include: at least 59.5% spray-dried mannitol; the active ingredient less than or equal to 10%, where at least 90% by weight of the active ingredient has a particle size of less than 100 Ám; 10-18% microcrystalline cellulose, having an average particle size of 50 µm and at least 99% by weight of the microcrystalline cellulose having a particle size below 250 µm; 1-4% sodium croscarmellose; and a lubricating agent 0.5-2%; oé, unless otherwise indicated, the percentages are expressed by weight of the total weight of the tablet. And also a process comprising: sieving and mixing the components except the lubricating agent; mixing all the components; and direct compression of the final mixture. The tablets of the invention decrease the disintegration times, give a good perception on the tongue after the disintegration, and overcome the problem of insufficient mechanical strength for packaging and transport operations.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200201440A ES2199061B1 (en) | 2002-06-10 | 2002-06-10 | TROUBLE-BASED TABLETS AND PROCEDURE FOR OBTAINING. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27309A1 true MA27309A1 (en) | 2005-05-02 |
Family
ID=29724735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27981A MA27309A1 (en) | 2002-06-10 | 2004-12-06 | ORODISPERSIBLE TABLETS AND PROCESSES FOR OBTAINING THEM |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20060165781A1 (en) |
| EP (1) | EP1534237B1 (en) |
| JP (1) | JP2005533045A (en) |
| KR (1) | KR100826819B1 (en) |
| CN (1) | CN100428926C (en) |
| AR (1) | AR040183A1 (en) |
| AT (1) | ATE422154T1 (en) |
| AU (1) | AU2003232415B2 (en) |
| BR (1) | BR0311708A (en) |
| CA (1) | CA2487834C (en) |
| CY (1) | CY1108961T1 (en) |
| DE (1) | DE60326074D1 (en) |
| DK (1) | DK1534237T3 (en) |
| EG (1) | EG25919A (en) |
| ES (2) | ES2199061B1 (en) |
| HK (1) | HK1076252A1 (en) |
| HR (1) | HRP20041158B1 (en) |
| IL (1) | IL165523A (en) |
| JO (1) | JO2560B1 (en) |
| MA (1) | MA27309A1 (en) |
| MX (1) | MXPA04012464A (en) |
| MY (1) | MY139585A (en) |
| NO (1) | NO334159B1 (en) |
| NZ (1) | NZ536966A (en) |
| PE (1) | PE20040069A1 (en) |
| PL (1) | PL207009B1 (en) |
| PT (1) | PT1534237E (en) |
| RU (1) | RU2321389C2 (en) |
| SA (1) | SA03240275B1 (en) |
| SI (1) | SI1534237T1 (en) |
| TW (1) | TWI288002B (en) |
| WO (1) | WO2003103629A1 (en) |
| ZA (1) | ZA200409894B (en) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| AU1323400A (en) * | 1998-10-27 | 2000-05-15 | Fuisz Technologies Ltd. | Microparticles containing peg and/or peg glyceryl esters |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| EP1670441A4 (en) * | 2003-10-07 | 2012-05-02 | Andrx Pharmaceuticals Llc | Rapidly disintegrating formulation |
| ES2238001B1 (en) | 2004-01-21 | 2006-11-01 | Vita Cientifica, S.L. | NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS. |
| JP2005306770A (en) * | 2004-04-21 | 2005-11-04 | Toa Eiyo Ltd | Intraoral quick collapse type preparation and method for producing the same |
| IS7290A (en) * | 2004-05-28 | 2005-11-29 | Actavis Group | Pharmaceutical formulations containing risperidone |
| DE102004034043A1 (en) * | 2004-07-13 | 2006-02-09 | Krka Tovarna Zdravil, D.D. | Solid pharmaceutical composition containing mirtazapine |
| GB0423800D0 (en) | 2004-10-27 | 2004-12-01 | Orexo Ab | New pharmaceutical formulations |
| WO2006087629A2 (en) * | 2005-02-21 | 2006-08-24 | Aurobindo Pharma Limited | Rapidly disintegrating composition of olanzapine |
| TWI383809B (en) * | 2005-06-29 | 2013-02-01 | Otsuka Pharma Co Ltd | Orally disintegrating powder comprising cilostazol |
| US20070092586A1 (en) * | 2005-10-26 | 2007-04-26 | Alamo Pharmaceuticals | Compositions and methods for the administration psychotropic drugs which modulate body weight |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
| CN100360128C (en) * | 2005-12-23 | 2008-01-09 | 北京科信必成医药科技发展有限公司 | Huperzine-A oral cavity disintegration tablet and its preparation method |
| CN100457100C (en) * | 2005-12-23 | 2009-02-04 | 北京科信必成医药科技发展有限公司 | Metoclopramide oral cavity disintegrating tablet and its production method |
| PE20080251A1 (en) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | USES OF DPP IV INHIBITORS |
| EP1852108A1 (en) * | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| CN102838599A (en) | 2006-05-04 | 2012-12-26 | 贝林格尔.英格海姆国际有限公司 | Polymorphs |
| US20080254118A1 (en) * | 2007-04-11 | 2008-10-16 | Hans-Werner Wernersbach | Process for preparing pramipexole dihydrochloride tablets |
| EP2076249A2 (en) * | 2006-10-27 | 2009-07-08 | FMC Corporation | Dry granulation binders, products, and use thereof |
| US20080254117A1 (en) * | 2007-04-10 | 2008-10-16 | Noel Cotton | Process for preparing pramipexole dihydrochloride tablets |
| TWI547282B (en) * | 2007-07-02 | 2016-09-01 | 愛戴爾製藥股份有限公司 | Orally disintegrating tablet compositions of lamotrigine |
| PL2572705T3 (en) * | 2007-10-01 | 2018-01-31 | Lesvi Laboratorios Sl | Orodispersible tablets |
| ES2729925T3 (en) | 2007-11-13 | 2019-11-07 | Meritage Pharma Inc | Corticosteroid Compositions |
| US20100310686A1 (en) * | 2007-11-14 | 2010-12-09 | Uxmal S.A., Chile | Extracts of deschampsia antarctica desv, with antineoplastic activity |
| PE20140960A1 (en) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | FORMULATIONS INVOLVING A DPP4 INHIBITOR |
| CA2728436C (en) | 2008-06-20 | 2016-07-26 | Merck Patent Gmbh | Directly compressible and rapidly disintegrating tablet matrix |
| FR2933299B1 (en) | 2008-07-04 | 2012-02-03 | Roquette Freres | MANNITOL ORODISPERSIBLE |
| BRPI0916997A2 (en) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | DPP-4 INHIBITOR AND ITS USE |
| KR101033975B1 (en) * | 2008-10-10 | 2011-05-11 | 이희엽 | Method for preparation of solid oral dosage forms of valsartan using the direct compression method and solid oral dosage forms thereby |
| EP2198857A1 (en) | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Oral dispersible tablet |
| DE102009016584A1 (en) * | 2009-04-06 | 2010-10-07 | Ratiopharm Gmbh | Orodispersible tablet containing a sildenafil salt |
| CN101874790B (en) * | 2009-04-29 | 2012-06-06 | 齐鲁制药有限公司 | Orally disintegrating tablet of Rasagiline or medicine salts thereof and preparation method thereof |
| CN101904824B (en) * | 2009-06-04 | 2012-07-18 | 齐鲁制药有限公司 | Olanzapine orally-disintegrating tablet preparation and preparation method thereof |
| EP2440210A4 (en) | 2009-06-12 | 2014-01-29 | Meritage Pharma Inc | Methods for treating gastrointestinal disorders |
| US20110105441A1 (en) * | 2009-10-30 | 2011-05-05 | Fmc Corporation | Stable Orally Disintegrating Tablets Having Low Superdisintegrant |
| KR102668834B1 (en) | 2009-11-27 | 2024-05-24 | 베링거 인겔하임 인터내셔날 게엠베하 | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| WO2011087705A2 (en) * | 2009-12-22 | 2011-07-21 | Fmc Corporation | Fine particle croscarmellose and uses thereof |
| WO2011138797A2 (en) | 2010-05-04 | 2011-11-10 | Cadila Healthcare Limited | Delayed release oral disintegrating pharmaceutical compositions of lansoprazole |
| ES2935300T3 (en) | 2010-05-05 | 2023-03-03 | Boehringer Ingelheim Int | combitherapy |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| JP6084826B2 (en) * | 2012-11-27 | 2017-02-22 | 古河産機システムズ株式会社 | Granule inspection device and granule inspection method |
| WO2016126012A1 (en) * | 2015-02-05 | 2016-08-11 | Boryung Pharmaceutical Co., Ltd | Tablet and method of preparing the same |
| KR101545268B1 (en) | 2015-02-05 | 2015-08-20 | 보령제약 주식회사 | Tablet and method of preparing the same |
| KR20180041217A (en) * | 2015-09-04 | 2018-04-23 | 주식회사 다이셀 | Ultra-high-speed disintegration tablet and its preparation method |
| CN107789328B (en) * | 2016-09-07 | 2021-02-26 | 成都康弘药业集团股份有限公司 | Orally disintegrating tablet containing donepezil hydrochloride and preparation method thereof |
| KR102290312B1 (en) | 2017-04-10 | 2021-08-17 | 주식회사 엘지생활건강 | Composition for tablet and preparing method thereof |
| WO2019004155A1 (en) * | 2017-06-27 | 2019-01-03 | 第一三共株式会社 | Tablet |
| WO2021126801A1 (en) * | 2019-12-16 | 2021-06-24 | Northwestern University | Lyophilized reagents |
| CN113730365A (en) * | 2021-08-10 | 2021-12-03 | 杭州新诺华医药有限公司 | Olanzapine orally disintegrating tablet and preparation method thereof |
| CN114224855B (en) * | 2021-12-01 | 2023-11-28 | 北京悦康科创医药科技股份有限公司 | Doxazosin mesylate buccal tablet and preparation method thereof |
| GB2627294A (en) * | 2023-02-20 | 2024-08-21 | Novumgen Ltd | A fast-disintegrating tablet of bisoprolol or pharmaceutically acceptable salts thereof and its process of preparation |
| CN116251067B (en) * | 2023-04-23 | 2024-06-07 | 淄博市中心医院 | Fluconazole tablet, preparation method and application |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0830005B2 (en) * | 1985-09-25 | 1996-03-27 | ゲルゲリイ、ゲルハルト | Disintegrating tablet and manufacturing method thereof |
| IT1238072B (en) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION OF CALCITONIN |
| FR2710637B1 (en) * | 1993-09-28 | 1995-12-08 | Roquette Freres | Mannitol powder of moderate friability and its preparation process. |
| FR2722408B1 (en) * | 1994-07-15 | 1996-10-04 | Vacher Dominique | NOVEL PROCESS FOR PRODUCING DRY PHARMACEUTICAL SHAPES WITH DELIVERY OF NEARLY INSTANTANEOUS AND PHARMACEUTICAL FORMS THUS PRODUCED |
| US5686107A (en) * | 1995-01-30 | 1997-11-11 | Fmc Corporation | Chewable pharmaceutical tablets |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| JPH10298062A (en) * | 1997-04-24 | 1998-11-10 | Pfizer Pharmaceut Co Ltd | Rapidly dissolving type tablet in oral cavity |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| SE9803240D0 (en) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
| AU3574500A (en) * | 1999-03-25 | 2000-10-16 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| JP2001058944A (en) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | Rapidly disintegrating solid formulation |
| US6740339B1 (en) * | 1999-06-18 | 2004-05-25 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
| EP1202716A1 (en) * | 1999-08-17 | 2002-05-08 | Novartis Consumer Health S.A. | Rapidly dissolving dosage form and process for making same |
| CA2342121C (en) * | 2000-03-29 | 2010-05-25 | Roquette Freres | Powdered mannitol and the procedure for preparing it |
-
2002
- 2002-06-10 ES ES200201440A patent/ES2199061B1/en not_active Expired - Fee Related
-
2003
- 2003-06-02 JO JO200361A patent/JO2560B1/en active
- 2003-06-02 PE PE2003000539A patent/PE20040069A1/en not_active Application Discontinuation
- 2003-06-04 MX MXPA04012464A patent/MXPA04012464A/en active IP Right Grant
- 2003-06-04 JP JP2004510749A patent/JP2005533045A/en active Pending
- 2003-06-04 AT AT03757165T patent/ATE422154T1/en active
- 2003-06-04 DE DE60326074T patent/DE60326074D1/en not_active Expired - Lifetime
- 2003-06-04 CA CA002487834A patent/CA2487834C/en not_active Expired - Lifetime
- 2003-06-04 AU AU2003232415A patent/AU2003232415B2/en not_active Expired
- 2003-06-04 EP EP03757165A patent/EP1534237B1/en not_active Expired - Lifetime
- 2003-06-04 DK DK03757165T patent/DK1534237T3/en active
- 2003-06-04 NZ NZ536966A patent/NZ536966A/en not_active IP Right Cessation
- 2003-06-04 BR BR0311708-1A patent/BR0311708A/en not_active Application Discontinuation
- 2003-06-04 CN CNB038135256A patent/CN100428926C/en not_active Expired - Lifetime
- 2003-06-04 US US10/517,110 patent/US20060165781A1/en not_active Abandoned
- 2003-06-04 WO PCT/IB2003/002446 patent/WO2003103629A1/en active Application Filing
- 2003-06-04 SI SI200331569T patent/SI1534237T1/en unknown
- 2003-06-04 ES ES03757165T patent/ES2320753T3/en not_active Expired - Lifetime
- 2003-06-04 PT PT03757165T patent/PT1534237E/en unknown
- 2003-06-04 PL PL374197A patent/PL207009B1/en unknown
- 2003-06-04 RU RU2004135377/15A patent/RU2321389C2/en active
- 2003-06-04 KR KR1020047020152A patent/KR100826819B1/en active IP Right Grant
- 2003-06-06 TW TW092115359A patent/TWI288002B/en not_active IP Right Cessation
- 2003-06-09 MY MYPI20032134A patent/MY139585A/en unknown
- 2003-06-09 EG EG2003060542A patent/EG25919A/en active
- 2003-06-10 AR ARP030102053A patent/AR040183A1/en not_active Application Discontinuation
- 2003-09-02 SA SA03240275A patent/SA03240275B1/en unknown
-
2004
- 2004-12-02 IL IL165523A patent/IL165523A/en active IP Right Grant
- 2004-12-06 HR HR20041158 patent/HRP20041158B1/en not_active IP Right Cessation
- 2004-12-06 MA MA27981A patent/MA27309A1/en unknown
- 2004-12-07 ZA ZA200409894A patent/ZA200409894B/en unknown
- 2004-12-21 NO NO20045577A patent/NO334159B1/en not_active IP Right Cessation
-
2005
- 2005-11-25 HK HK05110717.6A patent/HK1076252A1/en not_active IP Right Cessation
-
2009
- 2009-04-13 CY CY20091100430T patent/CY1108961T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27309A1 (en) | ORODISPERSIBLE TABLETS AND PROCESSES FOR OBTAINING THEM | |
| US8945618B2 (en) | Intrabuccally rapidly disintegrating tablet and a production method of the tablets | |
| RU2733410C2 (en) | Medicinal forms of ferric citrate (iii) | |
| Lira Soares et al. | Dry granulation and compression of spray-dried plant extracts | |
| WO2009043844A3 (en) | Orodispersible tablets | |
| WO2001085257A3 (en) | Opioid antagonist compositions and dosage forms | |
| CA2563440A1 (en) | Orally disintegrating tablets and methods of manufacture | |
| MY136524A (en) | New solid pharmaceutical formulations comprising telmisartan and preparation thereof | |
| CZ301589B6 (en) | Multiparticulate tablet | |
| MA29630B1 (en) | ACTIVE PHARMACEUTICAL INGREDIENT OF CANNABINOID FOR IMPROVED DOSAGE FORMS | |
| IE77165B1 (en) | Water-dispersible tablet containing acyclovir | |
| RU2007125122A (en) | PHARMACEUTICAL COMPOSITION OF HIV INTEGRASE CARBOXAMIDE INHIBITORS CONTAINING A COMPOSITION WITH CONTROLLED RELEASE SPEED | |
| EP1321142A1 (en) | Solid pharmaceutical composition for oral administration of Tegaserod | |
| WO2002056881A8 (en) | Fenofibrate tablets | |
| WO2008079343A3 (en) | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients | |
| Byyny | Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring | |
| MXPA02009819A (en) | Treatment of renal disorders. | |
| WO2004002398A3 (en) | Spherical pellet containing a water-soluble active ingredient | |
| CA2501772A1 (en) | Use of dihydroimidazolones for the treatment of epilepsy in dogs | |
| US20080095846A1 (en) | Pharmaceutical compositions of antihistamine and decongestant | |
| CN1325049C (en) | Composition containing epigallocatechin gallate | |
| US5560927A (en) | Co-processing method for making a free-flowing compressible powder and tablet therefrom | |
| JP4392478B2 (en) | Process for producing tablets from plant extracts | |
| BG108807A (en) | Amlodipine bezylate tablets with improved stability | |
| Ciurba et al. | Kinetics and Mechanism of Drug Release from Loratadine Orodispersible Tablets Developed without Lactose |